America in Transition Pages

Thursday, January 28, 2016

Breast Cancer Drug OK'd for Liposarcoma

(MedPage Today) -- Halaven is first agent to demonstrate survival benefit in rare cancer

from MedPage Today Washington Watch http://ift.tt/1OSLBi9
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)